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Abstract 
Chemical skin sensitizers produce allergic contact dermatitis, which is one of the most frequent 
occupational diseases associated with chemical exposures. Skin exposure is the major route of 
exposure when using plant protection products (PPPs). Therefore, skin sensitization is an 
important factor to be addressed during the regulatory risk assessment of PPPs. The main 
regulatory decision criterion considered when performing risk assessment for skin sensitizers is 
the dose applied. The equally important criteria “potency of the substance” is insufficiently 
considered by two potency categories as potency may vary up to five orders of magnitude. 
“Frequency of exposure” to the skin sensitizer is not considered at all. Consequently, an 
improved risk assessment methodology is essential to adequately assess health risks from skin 
sensitizers, especially for agricultural operators using PPPs. A quantitative risk assessment 
(QRA) approach for addressing PPPs sensitizing potential is proposed here. This QRA 
combines a methodology to derive a substance-specific threshold for skin sensitizers, a Derived 
No-Effect Level (DNEL), and an agricultural exposure model used for assessing chronic health 
risks of PPPs. The proposed QRA for skin sensitizing PPPs is a clear improvement over current 
risk assessment to ensure the safe use of skin sensitizers in an occupational context. 
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1 Introduction 
Chemical skin sensitizers are known to produce allergic contact dermatitis, which is one of the 
most frequent occupational diseases associated with exposure to chemicals (Diepgen and 
Coenraads, 1999; McDonald et al., 2006). Allergic contact dermatitis progresses in two stages 
as commonly observed with other forms of allergy. After a single exposure to a skin sensitizer 
during an initial induction phase, sensitization to the allergen is acquired. Subsequent 
exposures to the same skin sensitizer elicit the actual allergic reaction (elicitation phase) (see 
Appendix A1 for further information on the scientific background of skin sensitization). Allergic 
responses to skin sensitizers are driven by the amount of substance applied per area of 
exposed skin (expressed in µg/cm2) and referred to as external dose, by the potency of the skin 
sensitizer (i.e. its electrophilic reactivity), and by the frequency of exposure to the skin sensitizer 
(Friedmann, 2007; Kimber et al., 2008; Paramasivan et al., 2010). Yet, the main regulatory 
decision criterion currently considered in the EU when performing a risk assessment for skin 
sensitizing chemicals is the classification of a substance or mixture as skin sensitizer. The 
actual amount of substance reaching the skin is not considered for current risk assessment. 
According to the EU Regulation for Classification, Labelling and Packaging (CLP), a mixture 
containing a skin sensitizer is not considered having skin sensitizing properties if the 
concentration of the skin sensitizer in the mixture is below defined concentration limits of 0.1% 
or 1% (see Appendix A2 for further information on the classification criteria used in the EU CLP 
Regulation). However, this concentration-based approach does not sufficiently address potency, 
especially for strong sensitizers, since sensitization after exposure to strong sensitizers can 
occur at far lower concentrations than set forth in the CLP Regulation (Liden, 2008). Similarly, 
frequency of exposure is completely disregarded. Consequently, an improved risk assessment 
methodology for skin sensitizers is needed to adequately consider these three factors: dose, 
potency, and frequency of exposure to the skin sensitizers. All three are important in 
determining occurrence of sensitization. Ideally, a quantitative risk assessment (QRA) 
methodology would combine a quantitative model comparing predicted exposures to the 
specific skin sensitizer with an endpoint that has been derived considering these three 
influencing factors.  
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A number of authors have proposed QRA approaches for skin sensitizing chemicals, primarily 
focusing on cosmetic and household products and on the risk for consumers of such products 
(Api et al., 2006; Felter et al., 2002; Griem et al., 2003; ter Burg et al., 2010). Since the EU 
banned animal testing of cosmetic ingredients in 2013 (including tests for skin sensitization), 
considerable efforts have been and are being made in the cosmetic and fragrance industry to 
update skin sensitization QRA (Basketter and Safford, 2016; SCCS, 2017). Common to all 
these approaches is the aim to derive a quantitative endpoint to protect non-allergic individuals 
against skin sensitization. This endpoint is either called “No Expected Sensitizing Induction 
Level (NESIL)” (Api et al., 2006) or “Acceptable Non-Sensitizing Area Dose (ANSAD)” (Griem et 
al., 2003). Apart from focusing on risks for consumers, publications so far have concentrated on 
the scientific basis of skin sensitization; and appropriate use of uncertainty factors or 
sensitization assessment factors (SAFs) for deriving an endpoint, below which no sensitization 
occurs. Derived quantitative endpoints have so far not been combined with an exposure 
assessment, thus estimates for the likelihood of exposure to skin sensitizers have not been 
provided. The exposure assessment is a pre-requisite in order to perform a risk assessment 
where both the hazard of the substance is characterized as well as the exposure to the 
substance are considered.  
 
The present study aims at developing a QRA methodology for plant protection products (PPPs) 
which is an important group of skin sensitizing chemicals since skin exposure is the most 
significant route of entry when using PPPs (Anderson and Meade, 2014; Baldi et al., 2006; 
Macfarlane et al., 2013). Quantitative methodologies are available for chemicals (ECHA, 2012), 
biocides (ECHA, 2017) and cosmetics (Api et al., 2006; Basketter and Safford, 2016; Felter et 
al., 2002; Griem et al., 2003; SCCS, 2017; ter Burg, 2006). For PPPs, currently only a 
qualitative or hazard-based approach is implemented, which consists of wearing personal 
protective equipment (PPE) while using sensitizing products or dilutions. The QRA approach 
presented here uses a methodology to derive a substance-specific threshold for skin 
sensitizers, a Derived No-Effect Level (DNEL) (ECHA, 2012). The DNEL explicitly includes 
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potency and frequency of exposure being two important determinants of skin sensitization. 
Subsequently, the third determinant being the actual amount of substance reaching the skin is 
considered by using the DNEL in an agricultural exposure model used for assessing the chronic 
risks of PPPs to agricultural operators1 during the approval process of PPPs. The advantage of 
such an agricultural exposure model is that the estimated systemic PPP exposure is compared 
to a systemic endpoint. By doing this the maximum amount of PPP to which an operator may be 
exposed per day without any adverse health effects to be expected (Acceptable Operator 
Exposure Level, AOEL) can be defined. While the AOEL covers subacute and partially 
subchronic effects, it does not cover local skin effects such as irritation and sensitization. 
Hence, an endpoint reflecting skin sensitizing risk such as a DNEL is needed.  
 
The approach presented here may help to improve the risk assessment for skin sensitizing 
chemicals. In addition, it addresses appropriate exposure scenarios in the risk assessment. This 
will eventually lead to a better protection of operators using PPPs regularly. The proposed 
approach will be discussed considering both the toxicological as well as the cumulative and 
occupational exposure assessment perspective.  
 
2. Skin sensitizing plant protection products 
Plant protection products (PPPs) aim at protecting plants from damaging influences such as 
weeds, fungi or insects. They are primarily used in the agricultural sector but also in forestry, 
horticulture, amenity areas, and private gardens to protect crops or desirable or useful plants. 
Given that PPPs are biologically active, they do not only have the desired plant protecting 
effects but also drawbacks, such as potential toxicity to humans and other non-target species in 
the environment. PPPs therefore undergo an authorization process in most countries where the 
manufacturer is required to assess the risks to human health and the environment prior to 
putting a product on the market (EC, 2009; PSMV, 2010). The risk assessment data have to be 
                                               
1The term “operator” is used here according to EFSA (2014) to denominate persons who are involved in 
activities relating to the application of a plant protection product. 
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submitted by the manufacturer to governmental agencies. The appropriate authorities assess 
the data and eventually decide whether the health risks associated with the PPP use are 
acceptable and market approval can be granted. Assessing the PPP’s potential to induce skin 
sensitization is a data requirement for placing on the market in the EU and in Switzerland (EC, 
2013). Among the 1134 PPPs authorized by April 2018 in Switzerland, 323 products (i.e. 
28.5%) were classified as being skin sensitizers (FOAG). They contained chemical active 
substances or adjuvants and co-formulants possibly being skin sensitizers.  
 
PPP applications on agricultural crops are typically divided into four clearly separated tasks: (1) 
mixing and loading the PPP into a tank; (2) applying diluted PPP with spray equipment; (3) 
rinsing and cleaning the spray equipment; and (4) re-entering previously treated crops. The 
level of PPP exposure varies between these four tasks. Mixing and loading are usually tasks 
associated with the highest exposure because agricultural operators are handling the 
concentrated product. In addition, accidental spills of the concentrated product may lead to 
direct local skin exposure. Exposure during spraying of the diluted PPP greatly vary depending 
on the spray equipment used. Field crops such as cereals, potatoes, and sugar beets are 
predominantly sprayed with tractor-mounted boom sprayers or self-propelled sprayers. The 
operator often sits in a closed cabin, which significantly reduces exposure to the diluted PPP. 
Closed cabins may not, however, be available in all cases. Other crops such as grapes, stone 
or pome fruits are sprayed with tractor-mounted broadcast air-assisted sprayers. The tractors 
used in orchards and vineyards are usually smaller than those used in field crops and may not 
always include a closed cabin. Where the terrain is too steep to use machinery, operators use 
knapsack sprayers or backpack mist blowers. Hand held equipment is likewise used in 
greenhouses to spray certain vegetables such as tomatoes and cucumbers, as well as for 
spraying ornamental plants. Especially with hand-held equipment, exposure to the diluted 
product can be higher than when using a tractor-mounted spraying equipment (Baldi et al., 
2006; Baldi et al., 2012). In addition, agricultural operators are exposed to contaminated 
surfaces on the spraying equipment during rinsing and cleaning operations. They may also 
come in contact with sprayed plant material following application of PPPs during pruning and 
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harvesting activities. Apart from the factor determined by the characteristics of the equipment 
described above, a number of other factor determine the level of exposure during the three 
tasks described. An obvious factor is exposure time, which depends on the length of the tasks 
performed. Spraying operations usually last several hours while mixing, loading, rinsing, and 
cleaning are usually shorter; about 15 – 20 minutes (Baldi et al., 2006). In addition to intensity 
(exposure level) and duration (exposure time), another factor is the number of tasks performed 
over one working day (daily frequency) such as mixing and loading tasks needed to refill empty 
tanks. A further crucial factor is the type of protective clothing or equipment worn by the 
agricultural operators. Especially for skin sensitizing PPPs, exposure is clearly influenced by the 
area of unprotected skin as the concentrated or diluted PPP can deposit on bare arms or legs. 
Finally, an additional important factor is the frequency of exposure to PPPs over a growing 
season (seasonal frequency). In agriculture, the seasonal frequency is related to the crops 
grown on the farm. Although the number of treatments may vary depending on weather 
conditions or pest pressure, every crop usually has a more or less defined number of treatments 
over a growing season. In summary, five crucial exposure determinants govern PPP exposures 
among agricultural workers: spills and accidents, intensity, exposure time, daily task frequency, 
and seasonal treatment frequency.  
 
3 Rationale for a new quantitative risk assessment approach 
The following section outlines the specific rationale behind the quantitative risk assessment 
(QRA) approach proposed herein. In a first paragraph, the three most important factors 
contributing to skin sensitization are described. Secondly, reasons for why these three factors 
are currently insufficiently considered in the actual risk assessment methodology of PPPs are 
given. Finally, the new approach for QRA to address the mentioned limitations of current risk 
assessment of skin sensitizing PPPs is introduced. 
 
3.1 Dose-response relationships, potency of chemical skin sensitizers and frequency of 
exposure are the most important factors contributing to skin sensitization 
8 
Three principal factors determine whether a chemical induces sensitization2: (1) the dose that 
ultimately reaches the immune system; (2) the sensitizing potency of the chemical; and (3) the 
exposure pattern including the daily and seasonal exposure frequency. Inevitably, the three 
factors are linked as exposure is a function of intensity (i.e. dose), duration, and frequency. 
Hence, it is difficult to clearly denominate the contribution of each of the three factors. In the 
following, explanations of the impact of each factor is presented. 
(Menné and Wilkinson, 1992; Schnuch and Carlsen, 2011) (Fitzpatrick et al., 2017a; Fitzpatrick 
et al., 2017b) 
Dose influences the type and vigor of T-lymphocyte responses. The chemical dose (i.e. the 
amount of substance or ultimately the number of molecules) reaching the viable layers of the 
epidermis and finally encountering the immune system depends on a number of elements. 
Some elements are linked to the properties of the chemical, for example, to its molecular weight 
(MW) (it is assumed that compounds must have a MW less than 500 Da for efficient 
penetration3) and its solubility characteristics (lipid-soluble molecules penetrate much better 
than water-soluble ones having a log Kow ≤ 13) (Friedmann, 2007). Other elements are 
exposure-related such as the concentration (i.e. the amount of the substance on a given area or 
in a given volume) applied to the skin surface and the duration of contact with the skin. Kimber 
and colleagues were able to show that the immune response to a sensitizer primarily depends 
on the intensity of the sensitization stimulus, in other words, on the sensitizer dose per exposed 
skin area (Kimber et al., 2002; Kimber et al., 2008). Similarly, Friedmann (2007) demonstrated 
                                               
2 An important additional factor for the development of an allergic reaction to a chemical sensitizer is 
individual susceptibility, which is determined by age, gender and genetic factors such as the human 
leukocyte antigen (HLA) haplotype (Menné and Wilkinson, 1992; Schnuch and Carlsen, 2011). This factor 
will not be discussed further here. 
3 A recent study has shown that substances with a molecular weight (MW) larger than 500 Da may be 
skin sensitizers too. Among a data set of 2904 substances tested for skin sensitization, 33 substances (of 
a total of 197 substances with a MW > 500 Da) showed to be skin sensitizers (Fitzpatrick et al., 2017b). 
Similarly, of 525 substances having a log Kow ≤ 1, 100 substances were found to be skin sensitizers 
(Fitzpatrick et al., 2017a). 
9 
that the concentration in a given volume in percent (w/v) of material applied is not per se critical, 
but rather the concentration applied per area of exposed skin is the crucial determinant. Hence, 
the relevant dose metric in skin sensitization is the amount of chemical allergen that reaches a 
defined unit area of skin (usually expressed as µg substance per cm2 skin).  
 
The potency of chemical skin sensitizers can be defined as the relative ability of a chemical 
to induce sensitization (Ezendam et al., 2012). It is thought that the more protein-reactive a 
chemical is, the more potent it is as a sensitizer (Friedmann, 2007). Potency is thereby primarily 
driven by the ability of a chemical to form a hapten-protein complex, thus the higher the hapten-
protein complex concentration, the higher the potency of the chemical. Chemicals may 
potentially react with many different skin proteins at different amino acid sites, but in general, 
protein molecules are rich in nucleophiles and sensitizing chemicals are reactive electrophiles 
(Divkovic et al., 2005; Kaplan et al., 2012; Karlberg et al., 2008). For protein haptenation to 
occur (and hence lead to skin sensitization), a chemical must be electron deficient and have a 
high electrophilic reactivity. Chemicals with a higher electrophilic reactivity are thus more potent 
skin sensitizers. Chemical skin sensitizers vary by up to five orders of magnitude in skin 
sensitizing potency (Kimber et al., 2012). Some chemicals such as 2,4-Dinitrochlorobenzene 
(DNCB) (CAS 97-00-7), Diphenylcyclopropenone (CAS 886-38-4) and oxazolone (CAS 15646-
46-5), are very potent immunogens (i.e. substances producing an immune response) inducing 
contact sensitization in 100% of humans. The stronger the potency of the sensitizer, the lower 
the challenge dose needed to elicit a reaction in an already sensitized individual (Ezendam et 
al., 2012). Thus, dose and potency are inversely related. More potent sensitizers induce 
reactions at much lower doses than less potent ones (and similarly higher doses are needed 
with less potent ones for elicitation of an allergic reaction).  
 
Frequency of exposure is a third important determinant of the severity of the allergic reaction. 
Dose-response relationships are normally deducted from experiments with either a single dose 
or a low number of repeated doses (e.g. three exposures in the LLNA test). Yet, in occupational 
settings, the workers are normally repeatedly exposed weekly or even on a daily basis to 
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chemicals. Frequency of exposure plays a role in both induction and elicitation of skin 
sensitization. Basketter et al. (2006) showed that infrequent exposure at longer duration and 
with a higher concentration was significantly less likely to induce sensitization compared to more 
frequent, short duration, and lower concentration exposure. Similarly, the same degree of 
sensitization was induced by three exposures to 10 µg DNCB per cm2 skin as by one exposure 
to 60 µg of DNCB per cm2 skin (Paramasivan et al., 2010). Friedmann (2007) was able to show 
that during the early weeks and possibly months following initiation of sensitivity, repeated 
challenges with the sensitizer can increase the strength of sensitization and hence the 
reactivity. One possible explanation could be that repeated exposures result in chemical 
accumulation in the stratum corneum, acting as an epidermal reservoir as argued by Friedmann 
(2007). In conclusion, frequent exposure to several lower doses may induce a reaction that 
would otherwise only be induced by one exposure to a much higher dose. Frequency of 
exposure is hence equally important as dose and potency when assessing the risks of chemical 
skin sensitizers. 
 
3.2 Limitations of the risk assessment for skin sensitizers according to EU CLP 
Regulation 
It is important to understand that substances are to be classified as being hazardous according 
to the EU CLP Regulation’s criteria (Appendix A2). The hazard-based approach put forward in 
the Regulation is first to determine whether a chemical substance or a mixture containing the 
substance are either sensitizing or not based on the defined concentration limits. The approach 
put forward in the EU CLP Regulation suffers a main disadvantage for assessing occupational 
risk to skin sensitizers. As explained above, three main factors determine whether skin 
sensitization occurs or not: dose, potency and frequency. The EU CLP approach, however, 
primarily considers dose and to a lesser extent potency, whereas frequency of exposure is 
completely disregarded. Hence, both potency and frequency are either not sufficiently or not at 
all considered. Potency is not sufficiently considered since the EU CLP approach defines only 
two thresholds for skin sensitizers (0.1% and 1%). Liden (2008) argues that the concentration 
limit of 1% for category 1 (for substances where no data is available) is far too high to prevent 
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sensitization and allergic contact dermatitis from many potent skin sensitizers. With strong 
sensitizers, a single exposure is often sufficient for the induction of an immunological response. 
Since more than 4’000 chemicals have the potential to cause allergic contact dermatitis (de 
Groot, 2008), it is likely that this category of sensitizers contains a number of substances that 
should potentially have lower concentration limits. The concentration limit for this category will 
thus likely underestimate the risk for many substances present in this category. Given that the 
potency of skin sensitizers may vary up to five or six orders of magnitude, concentration limits 
only covering two orders of magnitude are not sufficient to assess the risk of the more potent 
sensitizers.  
 
Frequency of exposure to skin sensitizers, although equally important as potency, is completely 
disregarded by the EU CLP approach. Nevertheless, frequency of exposure is an important 
factor, given that PPPs are frequently applied over a growing season to protect the various 
crops grown on a farm against pests and diseases. Knowing that frequent exposure to several 
lower doses of a skin sensitizer may induce a reaction that would otherwise only be induced by 
one exposure to a much higher dose, frequency should be included in the risk assessment.  
 
3.3 Quantitative risk assessment for skin sensitizers 
Frequency should be considered in the quantitative risk assessment (QRA) methodology for 
substances or mixtures classified as sensitizers. The advantage of a QRA over a purely hazard-
based assessment is that the QRA allows to derive substance-specific thresholds. These can 
be used in an exposure assessment to determine whether the predicted exposure exceeds the 
thresholds. Ideally, the threshold to be used in such a QRA would consider – beside the dose - 
various potency levels as well as the frequency of exposure. The ECHA proposes an approach 
to derive a substance-specific threshold for skin sensitizers, a Derived No-Effect Level (DNEL) 
(ECHA, 2012). The DNEL considers the three relevant factors: dose, potency, and frequency of 
exposures (see section 7.1). This approach offers the opportunity to develop a QRA for skin 
sensitizers as the derived threshold can be used in an agricultural exposure model. Such a 
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model is used prior to the regulatory market approval of PPPs to determine the risks for 
agricultural operators. 
 
The aim of the present study is to propose an approach combining substance-specific DNELs 
for skin sensitizers with an agricultural exposure model. The DNEL is used as an endpoint to 
determine whether predicted skin exposure among agricultural operators exceeds the derived 
substance-specific DNEL. If so, specific risk mitigation measures need to be defined to control 
the risk.  
 
In the following, the procedure to calculate DNELs for skin sensitizers is described for a set of 
existing PPPs being classified as skin sensitizers. To address actual frequencies of exposure to 
skin sensitizers in agriculture, work practices of operators applying PPPs in horticultural 
production were investigated via interviews with greenhouse managers working in horticultural 
production. Subsequently, the procedure of using the DNELs in an agricultural exposure model 
to perform a QRA for skin sensitizing PPPs is explained.  
 
4. Material and Methods 
4.1 Derived No-Effect Level calculations for skin sensitizing plant protection products 
4.1.1 European Chemicals Agency’s guidance for a quantitative risk assessment for skin 
sensitizers 
The DNEL endpoint described in the QRA methodology for skin sensitizers proposed by ECHA 
(2012) reflects a maximum dose of skin sensitizer where no sensitization should occur. The 
DNEL (expressed as µg substance per cm2 area of skin) is derived from the EC3 value (in 
percent) obtained from the LLNA dose-response data (see Appendix A3 for further information 
on OECD test methods for identifying skin sensitizers). The EC3 value is thereby interpreted to 
be a Lowest Observed Adverse Effect Level (LOAEL) for induction within the process of deriving 
a DNEL (Basketter et al., 2003). To determine the correct starting point for the induction-specific 
DNEL, the EC3 value (converted in μg/cm2) is divided by (default) sensitization assessment 
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factors (SAFs) to account for inter- and intra-species variation, for dose response uncertainties 
and for uncertainties in the extrapolation of the LOAEL to the NOAEL (ECHA, 2012).  
 
4.1.2 Data used for the calculation of Derived No-Effect Levels 
The calculation was based on actual LLNA test data of PPPs submitted by manufacturers for 
the authorization in Switzerland. Access to these confidential test reports was possible given 
that some of the authors are involved in the official PPP authorization process in Switzerland. 
LLNA test data for some PPPs was obtained from documents in the authorization process in 
October 2014. The first selection criterion when screening the available dossiers was the PPP 
classification as a skin sensitizer according to the EU CLP Regulation. The second criterion was 
the availability of a positive LLNA test. Based on these two criteria, six PPPs were selected. 
Specific EC3 values and DNELs for these six PPPs were derived from their respective LLNA 
test data. The information related to product names and product characteristics is presented in 
an anonymized format (Product A – Product F) since the data submitted for PPP registration is 
confidential. 
 
4.1.3 Derived No-Effect Level calculation procedures 
Where the dose-response curve in the LLNA showed at least one SI value being above and 
below the threshold value of 3 (as for products E and F; see Supplemental Material), the EC3 
value was calculated using Equation 1 (Table 1). The data points immediately above and below 
the SI value of 3 on the LLNA dose-response plot are denoted with the coordinates (a; b) and 
(c; d), respectively (Figure 1) (Basketter et al., 2001).  
 
 Conc. [%] SI   EC3 [%] = c + �3 − db − d ∗ (a − c)� = 88.5 % 
 25 0.8  
c 50 1 d Equation 1 
a 100 3.6 b 
 
Table 1: Example of EC3 calculation based on a fictitious LLNA dose-response plot 
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Figure 1: Graphical illustration how the EC3 value for estimation of allergenic potency is 
determined based on local lymph node assay (LLNA) test data. The graph shows a dose–
response curve using the LLNA. The concentration of the test chemical required to produce a 
stimulation index (SI) of 3 (the EC3 value) is calculated using the formula EC3 =c + [(3−d)/(b−d)] 
×(a−c). The data points lying immediately above and below the SI value of 3 on the LLNA dose–
response plot have the coordinates (a,b) and (c,d), respectively. (adapted and reprinted from 
TRENDS in Pharmacological Sciences (22), Basketter, D., et al., “Measurement of allergenic 
potency using the local lymph node assay”. pp. 264-265, Copyright (2001) with permission from 
Elsevier). 
 
In the regular LLNA protocol, EC3 is derived from plots of SI vs. concentration by linear 
interpolation between the two points immediately above and below SI = 3 (Roberts, 2015). 
Where both SI values are above the threshold value of 3, Equation 1 fails giving a correct EC3 
value (as for products A, B and D; see Supplemental Material). In such a case the EC3 value 
has to be calculated with a log-linear extrapolation using the two SI values greater than 3 with 
the lowest of the SI values having the lowest test concentrations from the dose-response curve 
(Ryan et al., 2007). In Equation 2, the point with the higher SI was denoted (a, b) and the point 
with the lower SI was denoted (c, d).  
15 
Similarly, the log-linear extrapolation method outlined in Equation 2 fails where the dose-
response curve is bell-shaped (i.e. the SI value at the lower dose is higher than the SI at the 
higher dose as for Product C where the SI at 25% = 7.9 and the SI at 50% = 7.2; see 
Supplemental Material). Calculating EC3 with the log-linear extrapolation from Equation 2 would 
give an unrealistic EC3 value of 3200%. A more realistic EC3 value can be estimated by 
applying the rLLNA formula, where an EC3 can be calculated from a single dose LLNA 
(Roberts, 2015). Using the SI value of 7.9 at the dose 25% in Equation 3 results in an EC3 
value of 5%. 
 
Equation 2 EC3 extrapolated [%] = 10[log c+ 3−db−d ∗(loga−log c)] 
 
Equation 3 
𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙3 =  �𝑃𝑃𝑃𝑃𝑙𝑙𝑃𝑃𝑃𝑃𝑃𝑃78.5 (2) − 𝑃𝑃𝑃𝑃𝑙𝑙𝑃𝑃𝑃𝑃𝑃𝑃78.5 (𝑆𝑆𝑆𝑆 − 1)� +  0.87 ∗ log𝐷𝐷𝑙𝑙𝐷𝐷𝐷𝐷0.87  
 
Equation 4 EC3 [%] * 250 [μg/cm2/%] = EC3 [μg/cm2] 
 
Since the EC3 is usually expressed as a concentration (%), the value has to be converted to 
dose per skin area (μg/cm2) using the formula presented in Equation 4 (ECHA, 2012). The EC3 
in (μg/cm2) can be calculated by considering the dose volume of 25 μl (according to the 
standard LLNA protocol) and an estimated application area of 1 cm2 for the mouse ear. 
Assuming the density of the liquid is 1, the conversion factor to be applied to the EC3 (%) of 250 
is calculated by converting 25 μl/cm2 into μg/cm2. The converted EC3 values were subsequently 
used as a starting point for deriving substance-specific DNELs by applying sensitization 
assessment factors (SAFs).  
 
4.1.4 Application of sensitization assessment factors (SAFs). 
Sensitization assessment factors (SAFs) are numerical values that address the differences 
between the experimental data and the human situation by taking into account uncertainties in 
the extrapolation procedure and in the available data set. Five different SAFs were considered: 
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SAF for interspecies variation (mouse => human) 
Mouse EC3 data generally correlate well with human skin sensitization thresholds derived from 
historical predictive testing (Basketter et al., 2005). There are, however, cases where this 
correlation is poor and the two values may differ by a 10-fold or more. In view of this variation, 
ECHA proposes to use a default SAF of 10 for interspecies variation unless there is evidence of 
good correlation between EC3 and human NOAEL/LOAEL (ECHA, 2012). The Dutch National 
Institute for Public Health and the Environment (RIVM) suggests to use a factor of 3 instead of 
the classical factor of 10 (ter Burg, 2006; ter Burg et al., 2010). Yet, a recent publication of RIVM 
showed that an interspecies factor is required to ensure that the sensitization threshold 
determined in the LLNA does not underestimate the human threshold (Bil et al., 2017). While 
the geometric means of the probability distributions of murine and human sensitization threshold 
ratios were close to one, the 95th of these distributions resulted in an interspecies SAF of 15. In 
the present case, a SAF of 10 was applied to account for interspecies variation in accordance 
with the proposal by ECHA representing a compromise between the two proposals by RIVM. 
 
SAF for inter-individual difference among humans 
Humans differ in sensitivity to intoxications due to a multitude of biological factors such as 
genetic polymorphism (affecting e.g. toxicokinetics/metabolism), age, gender, health status and 
nutritional status. These differences can be the result of genetic and/or environmental 
influences. Inter-individual variation is greater in humans than in the more inbred experimental 
animal population. ECHA (2012) suggests to use a SAF of 5 for workers, based on the fact that 
this sub population does not cover the very young, the very old, and the very ill. In the present 
case a SAF of 10 was chosen for inter-individual differences as suggested by a number of 
authors (Basketter and Safford, 2016; ECHA, 2017; SCCS, 2017). 
 
SAF for dose-response relationship 
When the starting point for the DNEL calculation is a LOAEL, ECHA suggests to use an 
assessment factor between 3 (as minimum/majority of cases) and 10 (as maximum/exceptional 
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cases) (ECHA, 2012). As, in the present case, the EC3 value is considered to be a LOAEL, a 
SAF of 3 was applied. 
 
SAF for vehicle or matrix effect 
Skin sensitization studies are usually performed using a test solution in a simple matrix as 
recommended by the OECD testing guideline (OECD, 2010). ECHA (2012) recommends the 
use of a SAF of 3 if human exposure is expected in a matrix with no penetration enhancers. Yet, 
actual human exposure to PPPs might involve exposure to sensitizers in a different or more 
complex matrix which might increase the potential for induction of sensitization (e.g. matrix with 
irritant or/and penetration enhancing properties). PPPs typically contain solvents, surfactants 
and other chemical agents that aim at enhancing spray retention to the leaf surface. Such 
agents are known to affect dermal absorption, often increasing the absorption potential (EFSA, 
2012). In these cases, ECHA suggests considering the application of an additional SAF of 1-10-
fold, depending on the information available on the vehicle or matrix relevant for human 
exposure (Felter et al., 2002). Since skin sensitization studies are performed with the formulated 
product, the increased dermal absorption potential is already considered in the LLNA data. 
However, PPPs may be used in the field in tank mixes with additional substances with 
penetration enhancing properties. Thus a SAF of 5 was applied in the present case.  
 
SAF for different exposure scenarios 
According to ECHA, an additional SAF should be considered to account for differences in 
experimental exposure condition from actual human exposure scenarios (ECHA, 2012). One of 
the differences relates to the exposure frequency between the animal study and actual human 
exposure situations (Felter et al., 2002). In the LLNA, the mouse ear receives topical application 
of the test chemical once a day for three consecutive days. Skin sensitizers may nevertheless 
induce allergic responses at dosages, which do not induce a response in the LLNA. This occurs 
especially after prolonged and repeated exposure of the skin to low doses (de Jong et al., 2005; 
Paramasivan et al., 2010). Since it is unclear whether this occurs with most or only some 
sensitizing chemicals, ECHA suggests the application of a SAF of 1 – 10 fold to account for the 
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uncertainty related with repeated exposure. An interview-based study among greenhouse 
managers working in horticultural production was performed to understand the frequency of 
exposure to skin sensitizing PPPs (see Appendix A4 for further information). The interviews 
showed that a single operator might perform up to 60 applications of various PPPs in 
horticulture over a growing season from March to October. Horticulture was used as a worst-
case scenario since a multitude of different PPPs are frequently used in this production. Other 
agricultural production areas generally use PPPs less frequently than horticulture. In the present 
case, a SAF of 5 was applied to account for repeated exposures during application of PPPs in 
different agricultural production areas. 
 
Multiplication of the different SAFs resulted in a final SAF of 7’500 (Table 2). In conclusion, the 
DNEL representing the maximum dose of skin sensitizer where no sensitization should occur 
was calculated using Equation 5. 
 
Sensitization assessment 
factor 
Accounting for Default value 
used 
Interspecies variation Extrapolation mouse => human 10 
Inter-individual differences Differences among humans (here worker) 10 
Dose-response relationship Extrapolation LOAEL => NOAEL 3 
Vehicle or matrix effect Exposure via test solution => human 
exposure via PPP 
5 
Exposure conditions Frequency of exposure during test => 
frequency of exposure during real-use 
5 
Total  7’500 
 
Table 2: Overview of the different sensitization assessment factors assigned for the calculation 
of DNELs for skin sensitizers. 
 
Equation 5 DNEL =  LOAELSAFs = EC3 [μg/cm2]2250  
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4.2 Linking the Derived No-Effect Levels with an agricultural exposure model 
4.2.1 Agricultural operator exposure models 
Exposure models provide estimates for exposures to chemical substances during a particular 
working task such as the PPP application. In the approval process of PPPs, potential exposure 
is determined by using deterministic mathematical exposure models that are based on a 
number of parameters. Simulations of PPP exposure scenarios are calculated with the 
Agricultural Operator Exposure Model (AOEM) developed by the European Food Safety 
Authority (EFSA) (AOEM, 2013; EFSA, 2014). The AOEM estimates potential exposure 
absorbed via the skin and via inhalation when spraying PPPs using different types of spraying 
machinery (e.g. tractor-mounted boom and air-assisted sprayer as well as knapsack sprayer). 
The exposure is estimated by taking into account parameters that influence exposure such as 
application rate per hectare, treated area per day, percentage of dermal and inhalation 
absorption and body weight. Potential exposure can then be converted into systemic exposure 
using respective dermal absorption values. In the risk assessment during the approval process 
of PPPs, resulting exposure is compared to an endpoint defining the maximum amount of active 
substance to which an operator may be exposed per day without any adverse health effects to 
be expected over a life time (AOEL = Acceptable Operator Exposure Level (EC, 2006)). Taking 
into account typical PPP exposure patterns, the AOEL is based on the NOAEL from an oral 
short-term toxicity study (typically a 90-day study) provided that the critical endpoint(s) of the 
substance (e.g. reproductive/developmental toxicity) are covered and no irreversible effects 
occur at lower dose levels after chronic exposure. If a more sensitive, relevant end-point has 
been determined in a study investigating specific end-points (e.g. neurotoxicity, reproductive 
toxicity or developmental toxicity) the respective NOAEL is considered for AOEL setting. The 
AOEL does however not cover local skin effects such as irritation and sensitization. Thus, the 
AOEL is not appropriate to assess the risks to skin sensitizing PPPs. 
 
When performing risk assessment with an agricultural exposure model, a first step is to estimate 
exposure based on a “no PPE scenario”. In this step, it is assumed that the operator does not 
wear any personal protective equipment (PPE) such as gloves, coverall or face shield that 
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would reduce exposure (1st tier approach). In cases where the estimated exposures in the “no 
PPE scenario” exceed the exposure limit (i.e. the AOEL), various PPE can be incorporated into 
the model to assess whether the selected PPEs would allow a reduction in exposure below the 
AOEL (2nd tier approach). Each type of PPE has a specific protection factor. The AOEM uses 
measured values for hand and body protection using gloves or work wear depending on the 
application scenario chosen. Gloves reduce hand exposures by a factor of 0.01 to 0.11 (= 89-
99% protection for liquids). A coverall (i.e. certified work wear) reduces body exposure by a 
factor of 0.02 to 0.15 (= 85-98% protection), while a face shield reduces head exposure by a 
factor of 0.05 (= 95% protection) (AOEM, 2013).  
 
4.2.2 Use of agricultural exposure models to estimate exposure to skin sensitizers 
The AOEM allows to determine the amount of PPPs that is present on the outer skin surface. It 
can therefore be used to perform a risk assessment for skin sensitizing PPPs by comparing the 
amount of PPP on the skin surface to the DNEL for skin sensitizing PPPs. In the present case, 
exposure scenarios were calculated with the AOEM assuming that six skin sensitizer products 
would be applied in horticultural production using a knapsack sprayer at the actual dosage 
prescribed. The scenario “ornamentals, outdoor, upward spraying, manual knapsack” was 
chosen in the AOEM. An outdoor scenario had to be chosen as the current version of the 
AOEM provided by EFSA (version of March 2015) (EFSA, 2014) does not include a module for 
calculating indoor applications in greenhouses. The exposure scenario was selected as it is the 
pertinent exposure scenario for spraying horticultural plants. Moreover, the scenario “Hand-held 
upward spraying” is one of the scenarios leading to highest exposure among the scenarios 
present in the AOEM. Consequently, this can be considered a worst-case scenario.  
 
The model determines the amount of substance deposited on the skin or “external dermal 
exposure” [in µg substance per person]. To determine the potential exposure on bare skin 
during application of the six PPPs, a “no PPE scenario” was calculated in a first step. The 
resulting external dermal exposure values for hands, body and head were then added to the 
exposure occurring during mixing and loading of the product. As PPE has to be worn by default 
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during mixing and loading of skin sensitizing PPPs, the corresponding exposure values for the 
protected body parts were also considered. The sum of the external dermal exposure during 
mixing and loading with PPE for the three body parts plus their exposure during application 
without PPE was then divided by the respective default body surface area [in cm2] for hands, 
body, and head (Table 3). The amount obtained per cm2 of skin was then compared to the 
DNELs defining the maximum amount of substance of skin sensitizer on bare skin where no 
sensitization should occur. Skin sensitization can occur on any body parts wherever the DNEL 
is exceeded. Where the estimated exposure in the no PPE scenario exceeded the DNEL, 
exposure was calculated again with appropriate PPEs to each of the three body parts. Here, the 
measured values from the AOEM were used to determine potential exposure values for PPP 
application with PPE. Again, the external dermal exposure during mixing and loading with PPE 
was added to the obtained values and the sum of both exposures were compared to the DNELs 
(see Supplemental Material for Excel screenshots of the six products analyzed).  
 
Body part Body surface area [in cm2] 
Hands (palms and backs of both hands) 820 
Arms (both) 2’270 
Trunk (bosom, neck, shoulders, abdomen, back, genitals, 
buttocks) 
5’710 
Legs (both legs and thighs) 5’330 
Head 1’110 
 
Table 3: Default surface areas [in cm2] of different parts of the body of an adult (EFSA, 2014). 
The surface area of the body (= 13’310 cm2) is composed of arms, trunk, and legs assuming 
that an agricultural operator would at least wear a T-shirt and short trousers in a no PPE 
scenario. 
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 Product A Product B Product C Product D Product E Product F 
Type of PPP Fungicide Herbicide Fungicide Herbicide Fungicide Fungicide 
Application rate (kg active 
substance per hectare) 
2.448 0.75 0.249 0.06 1.325 0.072 
EC3 [%] 3.1 0.036 5.1 14.4 88.5 96.9 
EC3 [μg/cm2] 780 9 1284 3602 22115 24231 
DNEL [μg/cm2] 0.35 0.004 0.171 1.60 9.83 10.77 
EU CLP classification Skin Sens 1 Skin Sens 1 Skin Sens 1 Skin Sens 1B Skin Sens 1 Skin Sens 1 
Concentration limit 1% 1% 1% 1% 1% 1% 
Conc. of product in spray solution 0.46% 0.22% 0.15% 0.15% 0.28% 0.17% 
Spray solution classified according 
to EU CLP 
no no no no no no 
Exposure calculation AOEM model 
Exposure hands > DNEL 
necessary PPE 
yes (6’780%) 
no reasonable 
PPE 
yes (218’195%) 
no reasonable 
PPE 
yes (619%) 
gloves 
no (70%) yes (143%) 
gloves 
no (12%) 
Exposure body > DNEL 
necessary PPE 
yes (5’112%) 
coverall 
yes (366’326%) 
no reasonable 
PPE 
yes (2’171%) 
coverall 
yes (619%) 
coverall 
yes (164%) 
coverall 
no (95%) 
Exposure head > DNEL 
necessary PPE 
yes (183%) 
visor 
yes (10’761%) 
no reasonable 
PPE 
no (54%) no (13%) no (5%) no (2%) 
 
Table 4: Risk assessment for six skin sensitizing PPPs by comparing DNELs with estimated exposure of the skin calculated with the agricultural 
operator exposure model (AOEM). Where estimated exposure of the skin sensitizer on the skin exceeds the DNELs (shown in red), the necessary 
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personal protective equipment (PPE) is indicated to avoid induction of skin sensitization. For products A (hand exposure) and B (hand, body and head 
exposure) no reasonable PPE can be recommended since the DNEL is exceeded even when wearing PPE during application.. 
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5 Results 
5.1 Risk assessment using Derived No-Effect Levels for skin sensitizing plant protection 
products 
DNELs were derived for the six PPPs analyzed and they varied from 0.004 to 10.77 μg/cm2 
(Table 4). Hence the difference in potency between the strongest and the weakest sensitizer 
varied by a factor of 2’693. Comparing the estimated exposure during spraying of the products 
with the respective DNELs showed that five out of six products would need protective measures 
to cover bare skin to avoid sensitization. Product B was the strongest sensitizer among the six 
products analyzed. The DNEL would be exceeded for product B even if PPE would be worn 
during application (see Supplemental Material). Only product F of the five remaining products 
would not require PPE in order for the value to remain below the DNEL. PPE would be required 
for products A, C, D and E. Similar to product B, the DNEL for hand exposure is also exceeded 
for product A even if gloves are worn during application. It is noteworthy that none of the five 
products (A, B, C, D, E) would have required PPE during spraying if the protective measures 
had been derived based on the classification criteria set forth in the EU CLP Regulation. Being 
classified as Skin Sens 1 or 1B according to the EU CLP Regulation, the general concentration 
limit for the spray solution for these five products would be 1%. However, the actual spray 
solution concentration ranged from 0.15 to 0.46%. Since the concentration remained below the 
concentration limit of 1%, the spray solutions would not have to be classified as skin sensitizing. 
Hence, the purely qualitative hazard assessment according to the EU CLP Regulation would 
have underestimated the risk. Deriving product-specific DNELs with the suggested quantitative 
approach clearly showed that protective measures are needed for three products to avoid 
sensitization. 
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6 Discussion 
6.1 Limitations of the risk assessment for skin sensitizers according to EU CLP 
Regulation 
The considerations and analyses made in the present publication show that the current risk 
assessment for skin sensitizers based on the EU CLP Regulation approach bears two important 
limitations: 
 
1) A toxicological limitation: the actual risk is only insufficiently covered by the current 
approach as the two concentration limits defined by the EU CLP Regulation cover a rather 
narrow potency range of one order of magnitude, while the potency of skin sensitizers varies 
up to five orders of magnitude (Kimber et al., 2012). As shown in section 5, sensitization can 
occur at far lower concentrations than 0.1% since the EC3 (i.e. the concentration leading to 
the classification as skin sensitizer) of one of the assessed PPPs (product B) was as low as 
0.036%. Where the concentration-based EU CLP Regulation approach would have 
indicated no risk, the DNEL-approach showed that protective measures are needed to avoid 
sensitization. 
 
2) An exposure assessment limitation: the current risk assessment is based on the 
assumption of a single exposure scenario, that is, as long as the concentration limit is not 
exceeded during a single application of a PPP, no sensitization occurs. However, frequency 
of exposure plays an important role in developing an allergic contact dermatitis. Especially 
after prolonged and repeated skin exposure to low doses, the skin sensitizers may induce 
allergic responses at dosages, which do not induce responses in commonly used standard 
test assays such as the LLNA (de Jong et al., 2005; Paramasivan et al., 2010). As shown in 
section 4, frequency of exposure is a crucial component of the exposure assessment given 
that most companies interviewed estimated that a single worker applies PPPs 1-2 times per 
week over a growing period of eight months. 
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6.2 A toxicological approach to address the insufficient consideration of potency  
The current approach set forth in the EU CLP Regulation is unable to consider the full potency 
range of skin sensitizers. Consequently, the inability to identify strong allergens inevitably 
reduces the protection of operators regularly exposed to skin sensitizers. One aim of the 
present study was to address this potency issue by combining the DNEL approach proposed by 
ECHA with existing agricultural exposure models to develop a QRA for skin sensitizing PPPs. 
The results described in section 5 show that DNELs can be derived for PPPs if LLNA data is 
available. A critical part in the DNEL derivation process is the assignment of the different SAFs, 
which are often selected based on a weight of evidence approach (WoE) that involves expert 
judgements. In a WoE approach, different pieces of the available information are analyzed for 
their strengths and weaknesses based on the quality and consistency of the data and the 
relevance of the given information. In the present case, one could argue that the assigned total 
SAF of 7’500 is rather high. Yet, each of the five SAFs is substantiated both by scientific data 
and by recommendations made in the literature (see section 4.1.4). The number of SAFs to be 
assigned could be debated as some authors suggest to only define three different SAFs to 
account for inter-individual variability (SAF = 10), for vehicle/product matrix effects (SAF from 1 
to 10) and for use considerations (SAF from 1 to 10) (Api et al., 2006; Felter et al., 2002; ter 
Burg et al., 2010). Assigning the highest value of the three SAFs would result in a total SAF of 
1’000. It is important to note that the question of which SAF is to be assigned, is primarily 
relevant for moderate skin sensitizers (i.e. for products D, E and F where the resulting exposure 
was slightly below or above the DNEL, see section 5). In the case of moderate sensitizers, 
assigning an SAF of 1’000 or 2’000 can change the decision whether the DNEL is exceeded or 
not. However, these considerations have no influence on the QRA performed for strong 
sensitizers (e.g. products A and B for which the DNEL is exceeded by 3 or 4 orders of 
magnitude).  
 
A limitation of the proposed approach is that product-specific DNELs can currently only be 
derived if LLNA data is available, while test data from a guinea pig assay (Maximisation or 
Buehler) cannot be used to derive DNELs. Since 2013, the data requirements for the 
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authorization of new PPPs in the EU and Switzerland, regard the LLNA as the method of choice 
to assess skin sensitization4 (EC, 2013). New PPP authorizations in Switzerland often contain 
LLNA data tested on the formulated product (personal communication, Christoph Geiser, 
Federal Food Safety and Veterinary Office). However, the EU data requirements for PPPs also 
foresee that where a guinea pig assay is available for the substance to be authorized, further 
testing with a LLNA shall not be carried out for animal welfare reasons. It may thus be difficult to 
derive DNELs for many older PPPs that were authorized based on data from a guinea pig 
assay. It might be possible to derive LLNA potency based on the read-across from structurally 
related chemical substances for which experimental data are available or from QSAR for highly 
reactive electrophilic compounds (Roberts et al., 2016; Roberts and Aptula, 2008). The same 
sensitization assessments factors (SAFs) as when using LLNA data would need to be applied; 
however, on a case-by-case basis an additional SAF to account for the uncertainty related to 
the use of the read-across should be considered (ECHA 2012). 
 
The novel non-animal test methods for skin sensitization still have a restricted AOP mechanistic 
coverage and they can therefore not yet fully substitute the presently used animal tests 
(Appendix A3). At present, they primarily support the discrimination between skin sensitizers 
and non-sensitizers for the purpose of hazard classification and labelling. They currently do not 
predict potency as the LLNA would allow, nor can a precise EC3 value be determined, which is 
needed to derive a specific DNEL for skin sensitizers. It is nevertheless possible to determine 
potency classes or a rough EC3 value that could be used by adding an extra safety factor 
(Jaworska et al., 2015; Natsch et al., 2015). Since considerable research effort is currently 
ongoing to further develop the integrated testing strategy for skin sensitizers (Hoffmann et al., 
2018; Kleinstreuer et al., 2018), we are confident that the novel non-animal test methods could 
                                               
4 The ECHA announced in June 2016 that the REACH requirements for skin sensitization were changing, 
making non-animal testing the default requirement for the registration of chemicals 
(http://echa.europa.eu/view-article/-/journal_content/title/registrants-to-use-alternative-test-methods-for-
skin-sensitisation). It might be possible that these requirements might soon also apply to PPPs. 
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soon be integrated into the approach of linking DNELs with agricultural exposure models 
proposed herein. 
 
6.3 Exposure: approach to address the single exposure scenario issue 
Another aim of this publication was to suggest a QRA approach that would better take into 
account actual exposure to skin sensitizers when applying PPPs. Linking DNELs with 
agricultural exposure models may be an elegant approach to properly address varying exposure 
patterns to skin sensitizers since application frequency can be taken into account by including 
SAFs for different exposure conditions. The interviews with the greenhouse managers showed 
that operators in horticultural industry are significantly exposed to PPPs (Appendix A4). A single 
worker performs on average 1-2 PPP applications per week for about 1-4 h per day. The same 
person may thus perform more than 60 applications of various PPPs over a whole growing 
season from March to October. The interviews also showed that between 30-40% of the PPPs 
used are classified as skin sensitizers. Consequently, assuming that approximately every third 
application (= 33%) is performed with a skin sensitizing PPP, a single worker in horticultural 
production may be exposed up to 20 times to a skin sensitizer over a period of eight months. 
Exposure patterns similar to the horticultural production are likely to occur, especially in areas 
such as viticulture or arboriculture in which spraying is performed every 1 to 2 weeks over a 
growing season. The SAFs needed to derive the DNELs could be adapted to various 
agricultural production areas by defining production area-specific SAFs based on PPP 
application frequencies. 
 
6.4 Risk characterization combining toxicology and exposure 
From an occupational health and safety perspective, it is important to consider that the 
concentration limits stipulated in the EU CLP Regulation are classification criteria. As such they 
are used to decide whether a mixture is to be classified as being a skin sensitizer if substance A 
is mixed with substance B. However, classification criteria are of limited value for an 
occupational risk assessment as they are much too generic to reflect a specific work place 
setting. Occupational exposure limits (OELs) define a maximum concentration of a substance A 
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in an occupational setting. Use is considered safe as long as the concentration of substance A 
in the air or deposition of airborne substance onto the body remains below the OEL. Where a 
generic concentration limit may indicate a safe use of substance A, a better assessment of the 
occupational setting may reveal that the OEL is exceeded. This may be because substance A is 
applied with a specific method that cannot be covered by a generic concentration limit. The 
DNELs can be considered as specific OELs that assess the risk in a specific occupational 
setting as, for example, the spraying of PPPs. The proposed QRA approach thus addresses 
both the toxicological and the exposure-related limitation of the current risk assessment for skin 
sensitizers. Since DNELs are derived from substance-specific EC3 values, they account for the 
complete potency range of skin sensitizers given that the EC3 value is a continuous variable 
whereas the potency range of the EU CLP Regulation is an ordinal variable. Furthermore, the 
DNELs consider actual frequency of PPPs use as repeated exposure can be included as an 
additional assessment factor. The DNEL – in combination with the existing agricultural exposure 
models – can be used to develop a risk assessment that accounts for both the toxicology and 
the exposure during use of the product. This can be used to determine PPEs needed to protect 
exposed body parts where exposure is likely to exceed the DNEL and where a risk for the 
induction of an allergic skin reaction exists. 
 
The underlying paradigm of the here presented approach is that there is no induction as long as 
there is no contact between a skin sensitizer and bare skin. Thus, risk only exists if operators do 
not or insufficiently protect themselves during spraying. The interviews performed showed that 
the horticultural companies questioned were aware of the need for PPEs during spraying to 
protect operators from PPPs’ acute and chronic risks. The horticultural industry may however be 
an exception when compared to other areas with a high use of PPPs, such as agricultural 
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production5. Most horticultural companies are Swiss GAP certified6, where adherence to 
occupational safety measures is part of the certification scheme. Since the Swiss GAP 
certification is almost a prerequisite for market access, approximately 80% of the companies 
working in flower production (but only 6% working in nursery garden and shrub production) are 
certified (personal communication, Jardin Suisse). The positive outcome obtained in the 
interviews with regard to PPE use may partly be due to that 8 out of 9 companies within the 
interviewed sample were Swiss GAP certified. Furthermore, most people working in horticultural 
industry are employees and the employer has a legal obligation to take all necessary measures 
to ensure that the health of its employees is protected. In contrast, in agricultural production, 
approximately 81% of the people (= 128’000) working on farms are family members, while only 
about 19% (= 31’000) are employees (FSO, 2013; FSO, 2014). The legal obligations to ensure 
occupational health and safety of family members is less controlled by the Swiss cantonal 
authorities than for employees. Since protective measures are primarily relying on the individual 
responsibility of the farmers, some farmers might adhere less to PPEs than people working in 
horticultural industry. As there is currently no public national health register recording chronic 
effects from PPP use in Switzerland, it is difficult to conclude whether allergic contact dermatitis 
is frequent among Swiss PPP users. In the absence of conclusive data showing that allergic 
contact dermatitis is not frequently occurring among operators using PPPs, it is reasonable to 
adhere to a precautionary approach and to call for the necessity for adequate protection among 
PPP users.  
 
7 Conclusions and recommendations 
This study showed that the proposed QRA for skin sensitizing PPPs is a clear improvement 
over the current risk assessment approach based on the EU CLP Regulation to ensure the safe 
                                               
5 However, small horticultural companies (≤ 5 FTE) were underrepresented among the interviewed 
companies. These might invest less in occupational safety measures than larger companies do. 
6 Swiss GAP (Good Agricultural Practice) is a certification program ensuring a common standard for 
agricultural management practice bringing conformity to different retailers' supplier standards. 
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use of skin sensitizing chemicals in an occupational context. The QRA considers both the broad 
potency range of skin sensitizing chemicals and the frequency of exposure to PPPs. Both are 
crucial determinants for the development of an allergic reaction. From a practical point of view, 
the new QRA could be immediately implemented. However, to be accepted as a new risk 
assessment methodology for skin sensitizing chemicals, it is necessary to formally suggest this 
new approach to the respective regulatory channels such as the ECHA and EFSA. 
Nevertheless, a few points might need to be elucidated in the new QRA to ensure the safe use 
of skin sensitizing chemicals. 
 
The LLNA is an endpoint to avoid induction in non-sensitized persons. It does not allow the 
determination of a threshold of elicitation. DNELs will not protect already sensitized individuals. 
Methods and approaches to derive specific elicitation thresholds should ideally be developed, 
for example, by complementing the LLNA with a test with lower doses on already sensitized 
mice. The trend for determining the chemical classification is towards promoting non-animal test 
methods. Since the novel non-animal test methods for skin sensitization cannot currently be 
used to assign specific and precise potency to chemicals, there is a need to further develop the 
potency perspective in the non-animal test methods. Similarly, the novel non-animal test 
methods should also be expanded to derive elicitation thresholds. Considering the significant 
efforts that are being made by the cosmetics and fragrance industry to improve non-animal test 
methods, there is hope that such approaches will be available in the near future. In fact, multiple 
in vitro, in chemico, and in silico skin sensitization assays evaluated by the Cosmetics Europe 
Skin Tolerance Task Force (STTF) performed as well as or better than the LLNA in predicting 
human skin sensitization endpoints for both hazard and potency (Hoffmann et al., 2018; 
Kleinstreuer et al., 2018).  
 
Improving the risk assessment methodology for chemicals is an important step in assuring the 
health protection of people regularly using sensitizing products in an occupational setting. 
However, the proposed QRA approach only helps to improve operators’ health if people can be 
motivated to adhere to the necessary protective measures. Apart from performing a sound risk 
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assessment, there will always be the need for educating and training PPP users on how to 
adequately protect themselves. 
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Appendix A 
 
A1 Scientific background of skin sensitization 
Epidemiology of allergic contact dermatitis 
Chemical skin sensitizers are known to produce allergic contact dermatitis, and can be regarded 
as the most frequent manifestation of immunotoxicity in humans (Kaplan et al., 2012; Kimber et 
al., 2002). More than 4’000 chemicals that have been tested with patch testing showed having 
the potential to cause allergic contact dermatitis (de Groot, 2008). Allergic contact dermatitis is 
one of the most frequent diseases associated with chemical exposures both in the general 
population as well as in occupational settings. About 20% of the general population in Europe 
suffers from contact allergy to at least one contact allergen (Peiser et al., 2012; Thyssen et al., 
2007). Most common are allergies to nickel, fragrances and preservatives. Contact dermatitis 
ranks first among all occupational diseases in many countries (Diepgen and Coenraads, 1999; 
McDonald et al., 2006). The prognosis of occupational contact dermatitis is generally poor. A 
review of studies on the prognosis of contact dermatitis showed that less than half of the 
patients had healed after several years of follow-up (Diepgen, 2003). 
 
Immunological mechanism of skin sensitization 
The clinical picture of allergic contact dermatitis is a polymorphic pattern of skin inflammation 
characterized by a wide range of clinical features such as itching, redness, erythema, and 
clustered papulovesicles. The allergic reaction is typically elicited by much lower concentrations 
than those needed for inducing the immune response (Ezendam et al., 2012; Friedmann, 2007). 
Chemical skin sensitizers are haptens (i.e. low molecular weight molecules) that as such are 
unable themselves to directly stimulate an adaptive immune response. In order to elicit an 
immune response, they need to be attached to a larger carrier such as a protein (Kimber et al., 
2002). Consequently, immunogenicity must be acquired by stable association with protein and 
the formation of hapten-protein conjugates. A chemical must be inherently protein-reactive or 
must be metabolized to protein-reactive species for sensitization to proceed. A cascade of 
sequential and parallel steps has to occur in order for an allergic reaction to develop (Kaplan et 
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al., 2012; Kimber et al., 2002). The OECD has developed an adverse outcome pathway (AOP) 
for skin sensitization by chemical agents (OECD, 2012). The OECD AOP summarizes skin 
sensitization elicited by covalent binding of substances to proteins as eleven steps, which 
include four key events (KE): 
 
Key Event 1: The chemical sensitizer is converted to a reactive metabolite that covalently binds 
to nucleophilic sites in skin proteins (e.g. cysteine and lysine residues) forming hapten-protein 
complexes by covalent binding of the hapten to cell surface proteins. 
 
Key Event 2: Hapten binding to cell-surface proteins activates mitogen-activated protein kinase 
(MAPK) signaling pathways. This leads to the release of inflammatory cytokines and to the 
induction of cyto-protective pathways in keratinocytes. 
 
Key Event 3: Recognition and internalization of haptens lead to activation and maturation of 
skin-resident dendritic cells (DCs) (so-called Langerhans cells).  
 
Key Event 4: Dendritic cells migrate to lymph nodes to present major histocompatibility 
complex (MHC) molecules to naïve T-lymphocytes (T-cells), T-cell differentiation and 
proliferation as allergen-specific memory T-cells. 
 
A2 Classification criteria for skin sensitizers according to EU CLP Regulation 
Classification of substances 
The EU CLP Regulation defines classification criteria for various hazards to human health and 
the environment (EC, 2008). Within the EU CLP Regulation, skin sensitization is one of the 
health hazards to be assessed when placing a substance on the European market. If the test 
results of the OECD test methods for skin sensitization show that the test substance exceeds 
the thresholds for classification as skin sensitizer (Table 1), the substance is classified as being 
a skin sensitizer and labelled with the hazard statement “H317: May cause an allergic skin 
reaction”. In addition to the yes/no classification, the EU CLP Regulation also allows for a 
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potency assessment, with allocation of skin sensitizers into sub-category 1A (strong 
sensitizers), or sub-category 1B (weak to moderate skin sensitizers).  
 
OECD test guidelines Threshold for classification of a substance as skin sensitizer 
Mouse local lymph node assay (LLNA)  Stimulation Index ≥ 3 
Guinea pig maximization test (GPMT)  Response in ≥ 30% of the test animals 
Buehler occluded patch test  Response in ≥ 15% of the test animals 
 
Table 1: Thresholds for classification of a substance as a skin sensitizer according to the EU 
CLP Regulation (EC, 2008). 
 
The GPMT and the Buehler test allow to categorize skin sensitizers into weak, moderate and 
strong sensitizers, where potency is assigned based on test substance concentration and 
animal incidence of sensitization. The LLNA gives a more accurate picture of potency since 
potency is measured as a function of derived EC3-values. An inverse relationship exists 
between EC3-value and potency meaning that extremely potent sensitizers have extremely low 
EC3-values. Skin sensitizers vary by up to four or five orders of magnitude with respect to the 
minimum concentration required inducing skin sensitization. Potency is graded based on these 
minimum concentrations, each grade reflecting a concentration range of approximately one 
order of magnitude. The potency profile to skin sensitizers is broadly equivalent in mice and 
human. LLNA data obtained in mice can thus be used in risk assessment as No Observed 
Adverse Effect Level (NOAEL) for humans (Basketter et al., 2005). 
 
Classification of mixtures 
Many chemicals are supplied on the market as preparations of mixtures and often no data is 
available on the mixture as such but only on its individual components or substances. PPPs are 
usually tested for skin sensitization as a whole; however, they are frequently diluted in water 
before being sprayed on agricultural crops or horticultural plants. When assessing the risks of 
skin sensitizing PPPs, it is therefore important to know whether the diluted spray solution is still 
42 
classified as being sensitizing. According to the European Chemicals Agency (ECHA) Guidance 
on the application of the EU CLP criteria (ECHA, 2015), the spray solution can be regarded as a 
mixture of two components: the PPP is a skin sensitizing component A, which is diluted with a 
second component B (i.e. water). The spraying solution is often classified based on generic 
concentration limits for classifying a mixture as skin sensitizing. The mixture can be classified as 
a skin sensitizer when at least one of the skin sensitizing ingredients (e.g. the concentrated 
PPP) is present in the spray solution at or above the appropriate generic concentration limit for 
sub-category 1A or 1B, respectively (Table 2) (EC, 2008). In addition, specific concentration 
limits (below 0.1%) are defined for a limited number (ca. 90 substances) of very potent skin 
sensitizing chemicals (cf. Annex VI of the EU CLP Regulation).  
 
Component 
classified as 
Generic concentration 
limits for classification 
as skin sensitizer 
Concentration limits 
for elicitation of an 
allergic reaction 
Potency 
Skin sensitizer 
category 1 ≥ 1,0% ≥ 0,1% 
no data 
available 
Skin sensitizer sub-
category 1A ≥ 0,1% ≥ 0,01% 
EC3 ≤ 2% 
Skin sensitizer sub-
category 1B ≥ 1,0% ≥ 0,1% 
EC3 > 2% 
 => classification H317 => hazard information EUH208 
 
 
Table 2: Generic concentration limits of components of a mixture for the classification as skin 
sensitizers according to tables 3.4.5 and 3.4.6 of the EU CLP Regulation. Concentration limits 
for elicitation are used to protect already sensitized individuals (EC, 2008). 
 
A3 OECD test methods for identifying skin sensitizers 
Current test methods for skin sensitization 
Three OECD test methods can be used in identifying potential skin sensitizers according to the 
data requirements for placing of PPPs on the EU market (EC, 2013). The method of choice in 
the EU is currently the mouse local lymph node assay (LLNA) (OECD, 2010). In case the LLNA 
cannot be conducted, a guinea pig assay (Guinea Pig Maximisation Test (GPMT) or Buehler 
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occluded patch test) (OECD, 1992) can be performed instead. The LLNA is used both to 
determine skin sensitizing potential (hazard identification) and relative skin sensitization potency 
(hazard characterization). In both instances, the metric is cellular proliferation induced in 
draining lymph nodes following topical exposure to various dilutions of a chemical. The test is 
based on the fact that lymph node cell proliferation is causally and quantitatively correlated with 
the acquisition of skin sensitization (Basketter et al., 2002; Kimber et al., 2012). Three 
concentrations of the active substance are selected from a concentration series of 100%, 50%, 
25%, 10%, 5%, 2.5%, 1%, 0.5%, etc. These dilutions of the test substance are applied daily for 
three consecutive days at a volume of 25 µL to the upper surface of the mouse ear. Three days 
after the last exposure, the number of proliferating cells in the draining auricular lymph nodes is 
quantified using in vivo radioactive thymidine labeling as a measure of lymphocyte proliferation 
(i.e. memory T-cell clonal expansion). The test concentration causing a threefold increase of 
lymph node cell proliferation compared to the vehicle control is called the EC3 value (i.e. the 
effect concentration at which the stimulation index SI ≥ 3). Relative potency in the LLNA is 
based on the EC3 value, which is expressed as % concentration, molar value or dose per unit 
area (Kimber et al., 2003). The threshold for classification of a substance as skin sensitizer is a 
SI ≥ 3. The GPMT and the Buehler test both measure whether dermal application of a 
substance elicits skin reactions after previous induction by intradermal injection of the substance 
with adjuvant (GPMT) or by topical application of the substance without adjuvant (Buehler). 
These tests use a single test substance at a single concentration for induction, assumed to 
cause mild-to-moderate skin irritation. The severity of elicited skin responses compared to 
controls is recorded, yet classification as skin sensitizer is only based on the number of guinea 
pigs with positive skin test reactions (i.e. ≥ 30% positive animals in the GPMT and ≥ 15% in the 
Buehler test). Both the GPMT and the Buehler assay use only single test concentrations, so 
dose-effect relationships cannot be derived, whereas the mouse LLNA allows a dose-response 
assessment. 
 
Novel non-animal test methods for skin sensitization 
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Substantial effort has in recent years focused on reducing and ultimately replacing current 
animal test methods for skin sensitization. This is due to the widespread agreement that 
alternative test methods must be developed to replace, reduce and refine (3R strategy) the 
number of animals used for toxicology testing. The 3R strategy aims at encouraging alternatives 
to animal testing, but also to improve animal welfare and scientific quality where the use of 
animals cannot be avoided. Moreover, the EU banned animal testing of cosmetic ingredients in 
2013 which includes test for skin sensitization. The cosmetic industry is thus a major driver in 
developing non-animal test methods and has an urgent need for predictive and robust in vitro 
tests (Mehling et al., 2012). Within this remit, novel in silico, in chemico and in vitro test methods 
for skin sensitization have been developed both by industry consortia as well as by universities. 
Three alternative methods have recently been adopted as official OECD test methods, that is, 
the Direct Peptide Reactivity Assay (DPRA) (OECD., 2015a), the ARE-Nrf2 Luciferase Test 
Method (OECD., 2015b), and the Human Cell Line Activation Test (h-CLAT) (OECD, 2017). 
 
Direct Peptide Reactivity Assay (DPRA) provides an in chemico procedure to support the 
discrimination between skin sensitizers and non-sensitizers. The DPRA addresses the 
molecular initiating event leading to skin sensitization (i.e. protein reactivity) by quantifying the 
reactivity of test chemicals towards model synthetic peptides containing either lysine or 
cysteine. Cysteine and lysine percent peptide depletion values are calculated and used in a 
prediction model to categorize a substance in one of four classes of reactivity for supporting the 
discrimination between skin sensitizers and non-sensitizers. 
 
ARE-Nrf2 Luciferase Test Method provides an in vitro procedure to support the discrimination 
between skin sensitizers and non-sensitizers. It addresses the second KE on the AOP leading 
to skin sensitization in the keratinocytes. It includes inflammatory responses as well as gene 
expression associated with specific cell signaling pathways such as the antioxidant/electrophile 
response element (ARE)-dependent pathways. The cell line contains the luciferase gene under 
the transcriptional control of a constitutive promoter fused with an ARE element from a gene 
that is known to be up-regulated by contact sensitizers. The luciferase signal reflects the 
45 
activation by sensitizers of endogenous Nrf2 dependent genes. This allows quantitative 
measurement (by luminescence detection) of luciferase gene induction, using light producing 
luciferase substrates, as an indicator of the activity of the Nrf2 transcription factor in cells 
following exposure to electrophilic test substances. Currently, the only in vitro ARE-Nrf2 
luciferase test method covered is the KeratinoSensTM test method.  
 
Human Cell Line Activation Test (h-CLAT) provides an in vitro procedure used for supporting 
the discrimination between skin sensitizers and non-sensitizers. The h-CLAT method is 
proposed to address the third key event of the skin sensitization AOP by quantifying changes in 
the expression of cell surface markers associated with the process of activation of monocytes 
and DCs (i.e. CD86 and CD54), in the human monocytic leukaemia cell line THP-1, following 
exposure to sensitizing test chemicals. These surface molecules are typical markers of 
monocytic THP-1 activation and may mimic DC activation, which plays a critical role in T-cell 
priming. The changes of surface marker expression are measured by flow cytometry following 
cell staining with fluorochrome-tagged antibodies. The relative fluorescence intensity of surface 
markers compared to solvent/vehicle control are calculated and used in the prediction model, to 
support the discrimination between sensitizers and non-sensitizers. 
 
A4 Interviews with greenhouse managers to identify actual plant protection products use 
Face-to-face interviews of about an hour were performed with greenhouse managers working in 
horticultural companies in January and February 2016 to understand the frequency of exposure 
to skin sensitizing PPPs. The greenhouse managers were selected based on a list provided by 
the Swiss horticultural association. This list contained 12 horticultural companies in the German 
speaking part of Switzerland and one company in the French speaking part. These companies 
were considered by the Swiss horticultural association as likely willing to participate in such an 
interview. Nine companies (69%) accepted to participate in the interviews after having been 
contacted by mail and by phone. The interviews aimed at obtaining a better picture of actual 
PPP use and estimating the type and amount of PPP used. Horticultural production was chosen 
as a case study as a multitude of different PPPs are used. Since most horticultural plants 
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usually have a short growth period of a few weeks, the PPPs are applied on a regular basis 
resulting in a considerable cumulative PPP exposure for the operators over the year. An 
occupational hygiene survey questionnaire was developed by the authors and used in the 
interviews which were tape-recorded for later proofreading. Prior to the first interview, the 
questionnaire was tested with a Swiss horticultural association representative to check the 
questions for suitability, comprehension, and ambiguity. Questions included company 
characteristics and PPP use patterns such as type of products used, the dosage applied, the 
frequency and duration of use, and the method of application. Workers use of personal 
protection such as chemical protective suits, chemical resistant gloves, respirators, and 
technical equipment during application of the PPPs were also included.  
 
All participating companies stated that they generally treated all plant types with PPPs. The 
frequency of treatments depended primarily on the plant type and on the pest or disease 
damage. Among the different types of plants produced, the frequencies of treatment varied; 
flowers were treated twice per week to once per month; and nursery gardens and shrubs once 
per week to three times per year. Most companies emphasized that - especially in flower 
production - customers expect to buy “flawless” products and that treatments against pests and 
diseases attacking either leaves or blossoms were crucial to be able to sell the products. All 
companies used a wide spectrum of products or active substances. A considerable number of 
the products were classified as skin sensitizers: 25 fungicides (40% skin sensitizers), 20 
insecticides (40% skin sensitizers), 9 herbicides (33% skin sensitizers), and 4 growth regulators 
(no skin sensitizers). While fungicides and insecticides were both used in the greenhouse and 
open-air on a variety of plants, herbicides were primarily used outdoor in nursery gardens and 
shrubs to clean the surroundings of the cultivated plants from weeds. Growth regulator products 
were only used in the greenhouse, mostly on seasonal and balcony plants. Pests and diseases 
most frequently treated were fungal diseases (e.g. Mildews, Botrytis, Rusts) producing damages 
to leaves as well as insect pests such as spider mites, aphids, white flies, caterpillars and thrips 
producing damages to leaves and blossoms.  
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To spray small amounts of products on small areas, the machinery used were either hand 
sprayers or motorized knapsack sprayer. Mobile motorized sprayers were used for different 
types of spray operations in the greenhouse and open-air. All companies determined the need 
for spraying based on optical checks of plant damage or on damage threshold. All companies 
confirmed that two or more products for the same application were mixed. This was primarily 
done to reduce work load by avoiding additional spraying or to enlarge the spectrum of efficacy. 
Product types that were most often used in a mixture were fungicides and insecticides, and less 
often in combinations with the same type (e.g. a mixture of two herbicides). The frequency of 
spray operations performed by a single operator within the same week or month (i.e. the 
cumulative exposure) varied among the nine companies, mainly due to different types of plants 
cultivated and different necessities to treat. Most of the companies estimated that a single 
operator would perform 1-2 treatments per week, while two companies indicated 3-5 treatments 
per week. One of the companies producing nursery gardens and shrubs estimated that a single 
operator would apply PPPs only 1 – 2 times per month. The duration of treatments was 
estimated to range from 1 – 2 hours per day to 3 – 4 hours per day, depending on the area to 
be treated. Only exceptionally did the treatments last up to 5 – 8 hours per day. In conclusion, 
the same person may perform up to 60 applications of various PPPs in horticulture over a whole 
growing season from March to October. 
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Supplemental Material  
Screenshots of the Excel files used for the comparison of estimated exposures of hands, body 
and head resulting from the Agricultural Operator Exposure model (AOEM) with Derived No-
Effect Levels (DNELs) for products A - F in Table 4. The precise methodology is described in 
section 4 Materials and Methods. 
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Product A – Fungicide  
 
 
  
Concentration (%) Stimulation Index SI a 50 Dose 
10 10.6 b 21.1 SI
50 21.1 c 10 Dose 
100 21.2 d 10.6 SI
EC3ex 3.11945593
Using the two SI values greater than 3 with the lowest of the SI values having the lowest % concentration.
LOAEL (ug/cm2) 779.863982 DNEL 0.10398186 (AF=7500)
External dermal exposure mixing&loading (ML) (ug/person) External dermal exposure application (ug/person)
with PPE no PPE
hands 29 hands 5752
body 41 body 70708
head 8 head 203
Sum external dermal exposure ML with PPE+application no PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
hands 5781 820 7.05 7.05 0.9040038 6780
body 70749 13310 5.31547708 5.31547708 0.68159028 5112
head 211 1110 0.19009009 0.19009009 0.02437477 183
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE with PPE
hands 29 Gloves hands 59
body 41 Coverall body 1033
head 8 Visor head 10.15
Sum external dermal exposure ML with PPE+application with PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
Gloves hands 88 820 0.10731707 0.10731707 0.013761 103
Coverall body 1074 13310 0.08069121 0.08069121 0.01034683 78
Visor head 18.15 1110 0.01635135 0.01635135 0.00209669 16
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Product B – Herbicide 
  
  
Concentration (%) Stimulation Index SI a 10 Dose 
5 4.28 b 4.46 SI
10 4.46 c 5 Dose 
25 5.04 d 4.28 SI
EC3ex 0.03616698
Using the two SI values greater than 3 with the lowest of the SI values having the lowest % concentration.
LOAEL (ug/cm2) 9.041745237 DNEL 0.001205566 (AF=7500)
External dermal exposure mixing&loading (ML) (ug/person) External dermal exposure application (ug/person)
with PPE no PPE
hands 18 hands 2139
body 25 body 58756
head 5 head 139
Sum external dermal exposure ML with PPE+application no PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
hands 2157 820 2.6304878 2.630487805 29.0926999 218195
body 58781 13310 4.41630353 4.416303531 48.8434856 366326
head 144 1110 0.12972973 0.12972973 1.43478639 10761
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE with PPE
hands 18 Gloves hands 18
body 25 Coverall body 1033
head 5 Visor head 6.95
Sum external dermal exposure ML with PPE+application with PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
Gloves hands 36 820 0.043902439 0.04390244 0.48555271 3642
Coverall body 1058 13310 0.079489106 0.07948911 0.87913455 6594
Visor head 11.95 1110 0.010765766 0.01076577 0.11906734 893
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Product C – Fungicide 
 
  
Concentration (%) Stimulation Index SI a 25 Dose 
25 7.9 b 7.9 SI
50 7.2 c 50 Dose 
100 12.3 d 7.2 SI
logEC3 0.71053485
EC3 5.13493383
according to Roberts 2015
SI max SI SI-1 (SI-1)/SI max Prob78.5(SI-1)
78.5 3 2 0.02547771 -1.95185507
7.9 6.9 0.08789809 -1.35381258
LOAEL (ug/cm2) 1283.733458 DNEL 0.17116446 (AF=7500)
External dermal exposure mixing&loading (ML)(ug/person) External dermal exposure application (ug/person)
with PPE no PPE
hands 18 hands 851
body 25 body 49443
head 5 head 97
Sum external dermal exposure ML with PPE+application no PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
hands 869 820 1.0597561 1.0597561 0.08255266 619.1
body 49468 13310 3.71660406 3.71660406 0.28951524 2171.4
head 102 1110 0.09189189 0.09189189 0.00715818 53.7
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE with PPE
hands 18 Gloves hands 6
body 25 Coverall body 1033
head 5 Visor head 4.85
Sum external dermal exposure ML with PPE+application with PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
Gloves hands 24 820 0.02926829 0.02926829 0.002279935 17.099515
Coverall body 1058 13310 0.07948911 0.07948911 0.006192026 46.4401929
Visor head 9.85 1110 0.00887387 0.00887387 0.000691255 5.18441376
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𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙3 =  �𝑃𝑃𝑃𝑃𝑙𝑙𝑃𝑃𝑃𝑃𝑃𝑃78.5 (2) − 𝑃𝑃𝑃𝑃𝑙𝑙𝑃𝑃𝑃𝑃𝑃𝑃78.5 (𝑆𝑆𝑆𝑆 − 1)� +  0.87 ∗ log𝐷𝐷𝑙𝑙𝐷𝐷𝐷𝐷0.87  
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Product D – Herbicide 
 
  
Concentration (%) Stimulation Index SI a 50 Dose 
25 3.66 b 4.49 SI
50 4.49 c 25 Dose 
100 7.98 d 3.66 SI
EC3ex 14.4067745
Using the two SI values greater than 3 with the lowest of the SI values having the lowest % concentration.
LOAEL (ug/cm2) 3601.69363 DNEL 0.48022582 (AF=7500)
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE no PPE
hands 18 hands 259
body 25 body 39570
head 5 head 62
Sum external dermal exposure ML with PPE+application no PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
hands 277 820 0.33780488 0.33780488 0.00937906 70
body 39595 13310 2.97483095 2.97483095 0.08259534 619
head 67 1110 0.06036036 0.06036036 0.00167589 13
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE with PPE
hands 18 Gloves hands 1
body 25 Coverall body 1033
head 5 Visor head 3.1
Sum external dermal exposure ML with PPE+application with PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
Gloves hands 19 820 0.02317073 0.02317073 0.00064333 4.82496585
Coverall body 1058 13310 0.07948911 0.07948911 0.00220699 16.5524433
Visor head 8.1 1110 0.0072973 0.0072973 0.00020261 1.51955539
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Product E – Fungicide 
 
  
Concentration (%) Stimulation Index SI a 100 Dose (above SI=3)
25 0.8 b 3.6 SI
50 1 c 50 Dose (below SI =3)
100 3.6 d 1 SI
EC3 [%] 88.4615385
LOAEL (ug/cm2) 22115.3846 DNEL 2.94871795 (AF=7500)
External dermal exposure mixing&loading (ML) (ug/person) External dermal exposure application (ug/person)
with PPE no PPE
hands 18 hands 3443
body 25 body 64230
head 5 head 167
Sum external dermal exposure ML with PPE+application no PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
hands 3461 820 4.22 4.22 0.0191 143
body 64255 13310 4.83 4.83 0.0218 164
head 172 1110 0.15 0.15 0.0007 5
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE with PPE
hands 18 Gloves hands 32
body 25 Coverall body 1033
head 5 Visor head 8.35
Sum external dermal exposure ML with PPE+application with PPE (ug/person)
body surface ug/cm2 % of LOAEL % of DNEL 
Gloves hands 50 820 0.06 0.0003 2.1
Coverall body 1058 13310 0.08 0.0004 2.7
Face shield head 13.35 1110 0.01 0.0001 0.4
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Product F – Fungicide 
 
Concentration (%) Stimulation Index SI a 100 Dose (above SI=3)
20 1 b 3.2 SI
80 1.9 c 80 Dose (below SI =3)
100 3.2 d 1.9 SI
EC3 [%] 96.9230769
LOAEL (ug/cm2) 24230.7692 DNEL 3.23076923 (AF=7500)
External dermal exposure mixing&loading (ML) (ug/person) External dermal exposure application (ug/person)
with PPE no PPE
hands 18 hands 301
body 25 body 40715
head 5 head 65
Sum external dermal exposure ML with PPE+application no PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
hands 319 820 0.38902439 0.38902439 0.0016055 12
body 40740 13310 3.0608565 3.0608565 0.01263211 95
head 70 1110 0.06306306 0.06306306 0.00026026 2
External dermal exposure mixing&loading (ug/person) External dermal exposure application (ug/person)
with PPE with PPE
hands 18 Gloves hands 2
body 25 Coverall body 1033
head 5 Visor head 3.25
Sum external dermal exposure ML with PPE+application with PPE (ug/person)
body surface ug/cm2 ug/cm2 % of LOAEL % of DNEL 
Gloves hands 20 820 0.02439024 0.02439024 0.00010066 0.8
Coverall body 1058 7600 0.13921053 0.13921053 0.00057452 4.3
Visor head 8.25 1110 0.00743243 0.00743243 3.0674E-05 0.2
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